The success of Sildenafil initially sparked a surge for major pharmaceutical companies, however recent changes present a murky scenario for shareholders. Off-patent versions are eating into revenue, and continued https://leaayuu605510.ziblogs.com/41488385/viagra-and-pharma-a-volatile-bet